article thumbnail

Aesthetic Alchemy: “Artistry of Medical Aesthetic Procedures”

Roots Analysis

The treatments / products provided by medical aesthetics companies used for facial aesthetic procedures have been mentioned below: Botulinum toxin: It is a toxin produced by a bacterium, Clostridium botulinum , commonly referred to as Botox. These include increased public awareness and the presence of more licensed medical professionals.

Filler 40
article thumbnail

AbbVie Reports First-Quarter 2021 Financial Results

The Pharma Data

Global Botox Cosmetic net revenues were $477 million , an increase of 44.7 Global Botox Therapeutic net revenues were $532 million , an increase of 7.0 Botox Cosmetic*. Botox Therapeutic*. Global net revenues from the aesthetics portfolio were $1.141 billion , an increase of 34.9 percent on a comparable operational basis.

Botox 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medical Aesthetics: “Redefining Beauty through Medical Expertise”

Roots Analysis

Medical Aesthetics encompasses a wide variety of treatments, including injectables, such as Botox, dermal fillers, chemical peels, aesthetic implants and professional laser hair removal and body contouring devices. Currently, North America leads in terms of adoption of medical aesthetic procedures.

Filler 40
article thumbnail

AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results

The Pharma Data

– Full-Year Global Net Revenues from the Aesthetics Portfolio Were $2.590 Billion; Global Botox Cosmetic Net Revenues Were $1.112 Billion. – Full-Year Global Net Revenues from the Neuroscience Portfolio Were $3.496 Billion; Global Botox Therapeutic Net Revenues Were $1.387 Billion; Global Vraylar Net Revenues Were $951 Million.

Botox 52
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

percent increase since 2021, predominantly due to Botox sales for therapeutic uses. Late in 2022, AbbVie partnered with HotSpot Therapeutics and announced an exclusive worldwide collaboration and option to license agreement for their interferon regulatory factor 5 (IRF5) inhibitor program for autoimmune disease treatment.

Sales 98
article thumbnail

The TMJ Solution vsl cb | Blue Heron Health News

The Pharma Data

Splints, mouthguards, botox. Neither ClickBank nor the author are engaged in rendering medical or similar professional services or advice via this website or in the product, and the information provided is not intended to replace medical advice offered by a physician or other licensed healthcare provider. I, of course, knew even less.